Order results by:
Issue | Title | |
Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
"... of Simvastol (generic simvastatin) and results of its use for hyperlipidaemia treatment in clinical practice ..." | ||
Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
S. N. Tolpygina, S. Y. Martsevich | ||
"... Aim. To assess efficacy and safety of generic simvastatin, Simvahexal, in comparison with original ..." | ||
Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
"... ) received generic simvastatin. Initial simvastatin dose was 20 mg daily. Lipid plasma profile, liver enzymes ..." | ||
Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
"... Aim. To study efficacy and tolerability of original and generic simvastatin in patients ..." | ||
Vol 11, No 2 (2015) | NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE | Abstract similar documents |
S. Yu. Martsevich | ||
Vol 1, No 3 (2005) | EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim | ||
"... with atorvastatine generic, Tulip, in comparison with simvastatine generic, Vasilip, in hyperlipidemic patients ..." | ||
Vol 5, No 3 (2009) | ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT | Abstract similar documents |
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko | ||
"... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..." | ||
Vol 8, No 1 (2012) | THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE | Abstract similar documents |
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov | ||
"... stroke treated with simvastatin 40 mg/day in acute period of the disease. Materials and methods ..." | ||
Vol 9, No 4 (2013) | EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY | Abstract similar documents |
V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov | ||
"... in patients with the first ischemic stroke of hemispheric localization after prescription of simvastatin 40 mg ..." | ||
Vol 9, No 6 (2013) | EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE | Abstract similar documents |
T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov | ||
"... Aim. To study the effect of simvastatin added to standard therapy on the left ventricular structure ..." | ||
Vol 16, No 6 (2020) | Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment | Abstract similar documents |
V. Yu. Kopylov | ||
"... with simvastatin. Material and methods. The study involved 90 subjects, who were divided into control and main ..." | ||
Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
"... in response on combined therapy with fosinopril and simvastatin in postmenopausal metabolic syndrome (MS ..." | ||
Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
"... and very high risk, respectively. In-hospital rate of simvastatin administration reduced from 33.6% to 0 ..." | ||
Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
"... represented by generics. As for statins, only simvastatin could be found in almost all pharmacies. When ..." | ||
Vol 11, No 6 (2015) | Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? | Abstract similar documents |
I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov | ||
"... and simvastatin with model of cell membrane were studied by method of nuclear magnetic resonance spectroscopy ..." | ||
Vol 4, No 4 (2008) | ECONOMIC REASONS FOR GENERIC CHOICE | Abstract similar documents |
N. P. Kutishenko, S. Y. Martsevich, S. N. Tolpygina, J. V. Lukina | ||
"... Many generic medicines appear in the pharmaceutical market now. However, they are not always ..." | ||
Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko | ||
"... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..." | ||
Vol 12, No 1 (2016) | A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register | Abstract similar documents |
A. V. Zakharova, S. N. Tolpygina, V. P. Voronina, S. Yu. Martsevich | ||
"... Aim. To study the efficacy and safety of generic orlistat in comparison with the original drug ..." | ||
Vol 13, No 2 (2017) | STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | Abstract similar documents |
I. A. Latfullin, L. F. Galiullina, G. S. Musabirova, O. V. Aganova, Z. F. Kim, A. V. Aganov, V. V. Klochkov | ||
"... Aim. To study the location of pravastatin, simvastatin, fluvastatin and cerivastatin in molecular ..." | ||
Vol 5, No 6 (2009) | STATIN GENERICS: EFFICACY AND SAFETY RATIO | Abstract similar documents |
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova | ||
"... choice between original and generic drugs is discussed taking into account efficacy and safety ratio. ..." | ||
Vol 5, No 1 (2009) | PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES | Abstract similar documents |
S. N. Tolpygina, S. Yu. Martsevich | ||
"... The main differences between original and generic drugs as well as registration criteria ..." | ||
Vol 7, No 1 (2011) | THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS | Abstract similar documents |
O. V. Gaisenok | ||
"... of the clopidogrel generics appearance and prospects of their use is presented. ..." | ||
Vol 5, No 6 (2009) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC | Abstract similar documents |
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina | ||
"... Aim. To evaluate antihypertensive effects of new generic amlodipine (Stamlo M) in comparison ..." | ||
Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
N. A. Dmitrieva, S. N. Tolpygina | ||
"... ) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application ..." | ||
Vol 7, No 2 (2011) | WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT | Abstract similar documents |
N. P. Kutishenko, S. Yu. Martsevich, I. V. Vashurina | ||
"... The problem of generic drugs use in clinical practice and confirmation of their therapeutic ..." | ||
Vol 6, No 1 (2010) | COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova | ||
"... Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients ..." | ||
Vol 2, No 2 (2006) | PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? | Abstract similar documents |
S. Y. Martsevich | ||
"... of generic-statins equivalence to original drugs is considered. ..." | ||
Vol 1, No 1 (2005) | ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES | Abstract similar documents |
V. V. Yakusevich | ||
"... Wide presence of original drugs’ copies, the so-called “generics”, on the pharmaceutical market ..." | ||
Vol 18, No 2 (2022) | The problem of choice: original drug or generic? Emphasis on rosuvastatin | Abstract similar documents |
O. A. Polyakova, O. D. Ostroumova | ||
"... drugs to generic ones has become a common measure to contain these costs. While this is an important ..." | ||
Vol 7, No 1 (2011) | THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY | Abstract similar documents |
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev | ||
"... (Plavix) and its generic (Egitromb) in patients of high cardiovascular risk. Material and methods. Thirty ..." | ||
Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
"... Aim. Тo compare the cost-effectiveness of antihypertensive therapy based on a generic and original ..." | ||
Vol 14, No 1 (2018) | STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) | Abstract similar documents |
S. V. Povetkin, Ju. V. Luneva | ||
"... Aim. To study the therapeutic efficacy and safety of generic drug of ivabradine in comparison ..." | ||
Vol 6, No 2 (2010) | THE MODERN ASPECTS OF CLOPIDOGREL USE | Abstract similar documents |
E. N. Dankovtseva, D. A. Zateyshchikov | ||
"... complications are presented. The results of the comparative trails of original and generic clopidogrel are also ..." | ||
Vol 6, No 6 (2010) | COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE | Abstract similar documents |
Yu. V. Lukina, S. Yu. Martsevich | ||
"... of therapeutic efficacy and safety of combined antihypertensive therapy based on generics are important ..." | ||
Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
"... +indapamide, patients of group B (n=30) — a fixed combination of the generic enalapril+indapamide, patients ..." | ||
Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
"... – with double dose. In group B (non-fixed combination of generic enalapril/indapamide) 60% of patients achieved ..." | ||
Vol 9, No 5 (2013) | THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL | Abstract similar documents |
A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva | ||
"... Aim. To evaluate the therapeutic equivalence between generic perindopril (Parnavel, LLC Ozone ..." | ||
Vol 3, No 2 (2007) | ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY | Abstract similar documents |
N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, S. Y. Martsevich | ||
"... Aim. To develop a protocol for comparison of efficacy and safety of original drugs with generic ..." | ||
Vol 8, No 4 (2012) | THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova | ||
Vol 8, No 2 (2012) | THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev | ||
"... Aim. To compare two therapies based on the use of original or generic drugs in patients ..." | ||
Vol 14, No 6 (2018) | Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment | Abstract PDF (Eng) similar documents |
G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov | ||
"... Aim. Investigation of comparative dissolution kinetics of generic medicinal products containing ..." | ||
Vol 20, No 4 (2024) | Original drugs and generics: are there any differences from the clinician’s point of view? | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, O. M. Drapkina | ||
"... The article defines the original drug (OD) and examines the history of the appearance of generic ..." | ||
Vol 12, No 2 (2016) | COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS | Abstract similar documents |
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya | ||
"... of generics into clinical practice requires clear evidence of bioequivalence to the original drug. Aim ..." | ||
Vol 7, No 4 (2011) | VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL | Abstract similar documents |
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova | ||
"... Aim. To study the therapeutic equivalence of original and generic fosinopril in patients ..." | ||
Vol 8, No 2 (2012) | COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
O. P. Bobrova, M. M. Petrova | ||
"... and generic enalaprils in the treatment of the elderly patients with hypertension (HT). Material and Methods ..." | ||
Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
"... .32% of patients, enalapril 20 mg/day – 30.45%, simvastatin and atorvastatin 20 mg/day – 64.52% and 47 ..." | ||
Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
"... Aim. To study the clinical equivalence of original and generic drugs of bisoprolol in patients ..." | ||
Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
D. V. Nebieridze, A. S. Safarian | ||
Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
"... Aim. To compare the antiplatelet efficacy of the original and generic enterosoluble tableted ..." | ||
Vol 3, No 3 (2007) | COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich | ||
"... ) and generic (Bisogamma, WORWAG PHARMA GmbH & Co) bisoprolol were investigated in open-label cross-over ..." | ||
Vol 8, No 2 (2012) | UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE | Abstract similar documents |
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev | ||
Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
"... by therapies. There were not significant inter-group differences. Conclusion. ASA generic medicine Acecardol ..." | ||
Vol 2, No 4 (2006) | QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? | Abstract similar documents |
V. V. Iakusevich | ||
"... reduction is also connected with a huge number (80%) of reproduced drugs (generics). Considerable part among ..." | ||
Vol 5, No 1 (2009) | ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? | Abstract similar documents |
T. A. Kazakovtseva, N. A. Shostak | ||
"... информативно оценить тяжесть сердечной недостаточности (СН). Оценить чувствительность лабораторных маркёров СН ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
"... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..." | ||
Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
"... and its generic in patients with stable angina and concomitant chronic obstructive pulmonary disease (COPD ..." | ||
Vol 3, No 5 (2007) | CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich | ||
"... with cost of 727 rbl/month for Norvasc therapy. Conclusion. Generic Amlorus showed clinical ..." | ||
Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
"... Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients ..." | ||
Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
"... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) carvedilols with estimation of their serum level. And to study ..." | ||
Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
"... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
Vol 9, No 5 (2013) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva | ||
"... Aim. To study the clinical equivalence of the two low-dose combined drugs on the base of generic ..." | ||
Vol 9, No 2 (2013) | INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS | Abstract similar documents |
Zh. M. Sizova | ||
"... and generic drugs. The study showed clinical equivalence of the generic DeprenormR (Canonpharma Production ..." | ||
Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..." | ||
Vol 12, No 1 (2016) | Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease | Abstract similar documents |
E. I. Tarlovskaya, T. I. Chudinovskikh | ||
"... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..." | ||
Vol 1, No 3 (2005) | CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL | Abstract similar documents |
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina | ||
"... , simvastatin and diuretics were randomized to either bisoprolol (n=20) or сarvedilol (n=20) therapy group ..." | ||
Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
"... : acetylsalicylic acid 100 mg – up to 71.1%, simvastatin and atorvastatin 20 mg – up to 60.5% and 41 ..." | ||
Vol 8, No 1 (2012) | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova | ||
"... Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland ..." | ||
Vol 6, No 4 (2010) | HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD | Abstract PDF (Eng) similar documents |
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov | ||
"... , metoprolol, simvastatin) during 2 years after discharge from the hospital. Patients of the first studied ..." | ||
Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
"... , 29.7%) and simvastatin (n=121, 14.7%) were in second and third places. The target level of LDLC was 2 ..." | ||
Vol 9, No 3 (2013) | ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING | Abstract similar documents |
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova | ||
Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko | ||
"... prevention with statins are briefed. Therapeutic equivalence of statin generics with originator is discussed. ..." | ||
Vol 16, No 6 (2020) | Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level | Abstract similar documents |
C. M. Razzakova, L. E. Ziganshina | ||
"... . For each name, we studied the prices for the original brand and its lowest-priced generic. We compared ..." | ||
Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
Yu. V. Lukina, S. Yu. Martsevich | ||
"... ) are presented. Implementation of bisoprolol generics as well as bisoprolol usage in smoking cardiovascular ..." | ||
Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
A. N. Meshkov | ||
"... rare. Generic atorvastatin 80 mg OD in ATLANTIC study was effective and safe. However efficacy ..." | ||
Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
E. V. Shilova, S. Y. Martsevich | ||
"... on comparison of two amlodipines (original Norvasc and generic Stamlo M) are discussed. ..." | ||
Vol 15, No 2 (2019) | Cardiovascular medicine prices as an indicator of access to medicines and their rational use | Abstract similar documents |
C M. Razzakova, L. E. Ziganshina | ||
"... for the original brand drug and its lowest-priced generic. We compared medicine prices with international reference ..." | ||
Vol 13, No 2 (2017) | OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE | Abstract similar documents |
E. B. Babanskaya, L. V. Menshikova | ||
"... were related to the physicians’ choice of the original or generic MD and the factors that influence ..." | ||
Vol 6, No 3 (2010) | IS THERE AN ALTERNATIVE TO EJECTION FRACTION IN INSTRUMENTAL EVALUATION OF CHRONIC HEART FAILURE SEVERITY IN POST-MYOCARDIAL INFARCTION PATIENTS? | Abstract similar documents |
T. A. Kazakovtseva, N. A. Shostak | ||
"... была менее выраженной. Заключение. Установлен ряд наиболее ранних эхокардиографических маркёров ХСН. К ..." | ||
Vol 4, No 4 (2008) | EFFICACY OF CHRONIC HEART FAILURE COMBINED THERAPY DURING PERLINDOL USAGE IN ELDERLY POST INFARCTION PATIENTS WITH PSYCHOSOMATIC DISORDERS | Abstract similar documents |
M. E. Statsenko, I. A. Tyschenko | ||
"... of the first group received standard therapy (bisoprolol, lizinopril, simvastatin, acetylsalicylic acid ..." | ||
Vol 10, No 5 (2014) | DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov | ||
"... than 50% of patients received recommended DAPT at that they preferred generic drugs of clopidogrel ..." | ||
Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
L. N. Malay | ||
"... equivalence of generic drug with original rosuvastatin are presented. ..." | ||
Vol 15, No 2 (2019) | A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist | Abstract similar documents |
S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina | ||
"... are considered. The problem of less high efficacy of using replicated antihypertensive drugs (generics) compared ..." | ||
Vol 13, No 3 (2017) | COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebelnyy, M. M. Loukianov, A. N. Vorobyev, E. A. Pravkina, N. O. Myasnikova | ||
"... combinations, original and generic AHD. Data on the achievement/non-achievement of target blood pressure (BP ..." | ||
Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
A. V. Rudakova, N. V. Lomakin | ||
"... years. It was assumed that the patients were receiving either generic clopidogrel or ticagrelor for 1 ..." | ||
Vol 11, No 2 (2015) | HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER | Abstract similar documents |
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
"... the admission, however, the original drugs had been replaced by a variety of generics in most patients ..." | ||
Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
"... .3%. There were no significant differences in effects of original and generic clopidogrel on RPAR. Сlopidogrel ..." | ||
Vol 8, No 2 (2012) | PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION | Abstract similar documents |
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva | ||
"... times more in L/A group. Conclusion. Pharmacoeconomic analysis revealed that generic combination of L ..." | ||
Vol 14, No 2 (2018) | RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM MINIMIZATION OF EXPENSES TO EFFECTIVE MANAGEMENT | Abstract similar documents |
N. A. Nikolayev, Yu. P. Skirdenko, S. S. Bunova, A. V. Ershov | ||
"... than the class or cost of medicines, the original or generic nature of the drugs, or their dosage ..." | ||
Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
"... and pharmacokinetic parameters of branded generic preparations of acetylsalicylic acid (ASA) in buffered form ..." | ||
1 - 89 of 89 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)